ACS Chem Biol. 2020 Dec 18;15(12):3167-3175. doi: 10.1021/acschembio.0c00685. Epub 2020 Nov 29.
Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a family of natural products defined by a genetically encoded precursor peptide that is processed by associated biosynthetic enzymes to form the mature product. Lasso peptides are a class of RiPP defined by an isopeptide linkage between the N-terminal amine and an internal Asp/Glu residue with the C-terminal sequence threaded through the macrocycle. This unique lariat topology, which typically provides considerable stability toward heat and proteases, has stimulated interest in lasso peptides as potential therapeutics. Post-translational modifications beyond the class-defining, threaded macrolactam have been reported, including one example of Arg deimination to yield citrulline (Cit). Although a Cit-containing lasso peptide (i.e., citrulassin) was serendipitously discovered during a genome-guided campaign, the gene(s) responsible for Arg deimination has remained unknown. Herein, we describe the use of reactivity-based screening to discriminate bacterial strains that produce Arg- versus Cit-bearing citrulassins, yielding 13 new lasso peptide variants. Partial phylogenetic profiling identified a distally encoded peptidyl arginine deiminase (PAD) gene ubiquitous to the Cit-containing variants. Absence of this gene correlated strongly with lasso peptide variants only containing Arg (i.e., -citrulassin). Heterologous expression of the PAD gene in a -citrulassin producer resulted in the production of the deiminated analog, confirming PAD involvement in Arg deimination. The PADs were then bioinformatically surveyed to provide a deeper understanding of their taxonomic distribution and genomic contexts and to facilitate future studies that will evaluate any additional biochemical roles for the superfamily.
核糖体合成和翻译后修饰肽(RiPPs)是一类天然产物,其特征是具有一个基因编码的前体肽,该前体肽被相关的生物合成酶加工,形成成熟产物。套索肽是一类 RiPP,其特征是 N 端胺和内部 Asp/Glu 残基之间存在异肽键,C 端序列穿过大环。这种独特的套索拓扑结构通常对热和蛋白酶具有相当的稳定性,这激发了人们对套索肽作为潜在治疗药物的兴趣。除了定义类别的穿线大环内酯之外,还报道了其他翻译后修饰,包括一个 Arg 脱亚胺化为瓜氨酸(Cit)的例子。尽管在基于基因组的研究中偶然发现了含有 Cit 的套索肽(即 citrulassin),但负责 Arg 脱亚胺化的基因仍然未知。本文描述了使用基于反应性的筛选来区分产生 Arg-和 Cit-带 citrulassins 的细菌菌株的方法,得到了 13 种新的套索肽变体。部分系统发育分析确定了一个普遍存在于含 Cit 变体中的远端编码的肽基精氨酸脱亚氨酶(PAD)基因。该基因的缺失与仅含有 Arg 的套索肽变体(即-citrulassin)密切相关。在-citrulassin 产生菌中异源表达 PAD 基因导致脱亚胺化类似物的产生,证实了 PAD 参与 Arg 脱亚胺化。然后对 PAD 进行生物信息学调查,以更深入地了解它们的分类分布和基因组背景,并为将来评估该超家族的任何其他生化作用的研究提供便利。